Global Neuromuscular Blocking Drug Market Research Report 2023
Neuromuscular blocking drugs cause paralysis of the affected skeletal muscles by blocking neuromuscular transmission at the neuromuscular junction.
According to QYResearch’s new survey, global Neuromuscular Blocking Drug market is projected to reach US$ 5079 million in 2029, increasing from US$ 3815 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neuromuscular Blocking Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuromuscular Blocking Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Neuromuscular Blocking Drug market is projected to reach US$ 5079 million in 2029, increasing from US$ 3815 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neuromuscular Blocking Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuromuscular Blocking Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Hikma Pharmaceuticals
- Merck
- Novartis
- Bayer
- Pfizer
- AbbVie
- GSK
- Non-polarizing Agents
- Depolarizing Agents
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromuscular Blocking Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market by Application
1.3.1 Global Neuromuscular Blocking Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Neuromuscular Blocking Drug Market Perspective (2018-2029)
2.2 Neuromuscular Blocking Drug Growth Trends by Region
2.2.1 Global Neuromuscular Blocking Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuromuscular Blocking Drug Historic Market Size by Region (2018-2023)
2.2.3 Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029)
2.3 Neuromuscular Blocking Drug Market Dynamics
2.3.1 Neuromuscular Blocking Drug Industry Trends
2.3.2 Neuromuscular Blocking Drug Market Drivers
2.3.3 Neuromuscular Blocking Drug Market Challenges
2.3.4 Neuromuscular Blocking Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Neuromuscular Blocking Drug Players by Revenue
3.1.1 Global Top Neuromuscular Blocking Drug Players by Revenue (2018-2023)
3.1.2 Global Neuromuscular Blocking Drug Revenue Market Share by Players (2018-2023)
3.2 Global Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuromuscular Blocking Drug Revenue
3.4 Global Neuromuscular Blocking Drug Market Concentration Ratio
3.4.1 Global Neuromuscular Blocking Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromuscular Blocking Drug Revenue in 2022
3.5 Neuromuscular Blocking Drug Key Players Head office and Area Served
3.6 Key Players Neuromuscular Blocking Drug Product Solution and Service
3.7 Date of Enter into Neuromuscular Blocking Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NEUROMUSCULAR BLOCKING DRUG BREAKDOWN DATA BY TYPE
4.1 Global Neuromuscular Blocking Drug Historic Market Size by Type (2018-2023)
4.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029)
5 NEUROMUSCULAR BLOCKING DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Neuromuscular Blocking Drug Historic Market Size by Application (2018-2023)
5.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neuromuscular Blocking Drug Market Size (2018-2029)
6.2 North America Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neuromuscular Blocking Drug Market Size by Country (2018-2023)
6.4 North America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Neuromuscular Blocking Drug Market Size (2018-2029)
7.2 Europe Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neuromuscular Blocking Drug Market Size by Country (2018-2023)
7.4 Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Neuromuscular Blocking Drug Market Size (2018-2029)
8.2 Asia-Pacific Neuromuscular Blocking Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Neuromuscular Blocking Drug Market Size (2018-2029)
9.2 Latin America Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2023)
9.4 Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neuromuscular Blocking Drug Market Size (2018-2029)
10.2 Middle East & Africa Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Hikma Pharmaceuticals
11.1.1 Hikma Pharmaceuticals Company Detail
11.1.2 Hikma Pharmaceuticals Business Overview
11.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Introduction
11.1.4 Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.1.5 Hikma Pharmaceuticals Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Neuromuscular Blocking Drug Introduction
11.2.4 Merck Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Neuromuscular Blocking Drug Introduction
11.3.4 Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Neuromuscular Blocking Drug Introduction
11.4.4 Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neuromuscular Blocking Drug Introduction
11.5.4 Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Neuromuscular Blocking Drug Introduction
11.6.4 AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.6.5 AbbVie Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Neuromuscular Blocking Drug Introduction
11.7.4 GSK Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.7.5 GSK Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromuscular Blocking Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market by Application
1.3.1 Global Neuromuscular Blocking Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Neuromuscular Blocking Drug Market Perspective (2018-2029)
2.2 Neuromuscular Blocking Drug Growth Trends by Region
2.2.1 Global Neuromuscular Blocking Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuromuscular Blocking Drug Historic Market Size by Region (2018-2023)
2.2.3 Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029)
2.3 Neuromuscular Blocking Drug Market Dynamics
2.3.1 Neuromuscular Blocking Drug Industry Trends
2.3.2 Neuromuscular Blocking Drug Market Drivers
2.3.3 Neuromuscular Blocking Drug Market Challenges
2.3.4 Neuromuscular Blocking Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Neuromuscular Blocking Drug Players by Revenue
3.1.1 Global Top Neuromuscular Blocking Drug Players by Revenue (2018-2023)
3.1.2 Global Neuromuscular Blocking Drug Revenue Market Share by Players (2018-2023)
3.2 Global Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuromuscular Blocking Drug Revenue
3.4 Global Neuromuscular Blocking Drug Market Concentration Ratio
3.4.1 Global Neuromuscular Blocking Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromuscular Blocking Drug Revenue in 2022
3.5 Neuromuscular Blocking Drug Key Players Head office and Area Served
3.6 Key Players Neuromuscular Blocking Drug Product Solution and Service
3.7 Date of Enter into Neuromuscular Blocking Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NEUROMUSCULAR BLOCKING DRUG BREAKDOWN DATA BY TYPE
4.1 Global Neuromuscular Blocking Drug Historic Market Size by Type (2018-2023)
4.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029)
5 NEUROMUSCULAR BLOCKING DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Neuromuscular Blocking Drug Historic Market Size by Application (2018-2023)
5.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neuromuscular Blocking Drug Market Size (2018-2029)
6.2 North America Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neuromuscular Blocking Drug Market Size by Country (2018-2023)
6.4 North America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Neuromuscular Blocking Drug Market Size (2018-2029)
7.2 Europe Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neuromuscular Blocking Drug Market Size by Country (2018-2023)
7.4 Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Neuromuscular Blocking Drug Market Size (2018-2029)
8.2 Asia-Pacific Neuromuscular Blocking Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Neuromuscular Blocking Drug Market Size (2018-2029)
9.2 Latin America Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2023)
9.4 Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neuromuscular Blocking Drug Market Size (2018-2029)
10.2 Middle East & Africa Neuromuscular Blocking Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Hikma Pharmaceuticals
11.1.1 Hikma Pharmaceuticals Company Detail
11.1.2 Hikma Pharmaceuticals Business Overview
11.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Introduction
11.1.4 Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.1.5 Hikma Pharmaceuticals Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Neuromuscular Blocking Drug Introduction
11.2.4 Merck Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Neuromuscular Blocking Drug Introduction
11.3.4 Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Neuromuscular Blocking Drug Introduction
11.4.4 Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neuromuscular Blocking Drug Introduction
11.5.4 Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Neuromuscular Blocking Drug Introduction
11.6.4 AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.6.5 AbbVie Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Neuromuscular Blocking Drug Introduction
11.7.4 GSK Revenue in Neuromuscular Blocking Drug Business (2018-2023)
11.7.5 GSK Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Neuromuscular Blocking Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Non-polarizing Agents
Table 3. Key Players of Depolarizing Agents
Table 4. Global Neuromuscular Blocking Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Neuromuscular Blocking Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neuromuscular Blocking Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neuromuscular Blocking Drug Market Share by Region (2018-2023)
Table 8. Global Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neuromuscular Blocking Drug Market Share by Region (2024-2029)
Table 10. Neuromuscular Blocking Drug Market Trends
Table 11. Neuromuscular Blocking Drug Market Drivers
Table 12. Neuromuscular Blocking Drug Market Challenges
Table 13. Neuromuscular Blocking Drug Market Restraints
Table 14. Global Neuromuscular Blocking Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neuromuscular Blocking Drug Market Share by Players (2018-2023)
Table 16. Global Top Neuromuscular Blocking Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Table 17. Ranking of Global Top Neuromuscular Blocking Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neuromuscular Blocking Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuromuscular Blocking Drug Product Solution and Service
Table 21. Date of Enter into Neuromuscular Blocking Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuromuscular Blocking Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Neuromuscular Blocking Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neuromuscular Blocking Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neuromuscular Blocking Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Neuromuscular Blocking Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Hikma Pharmaceuticals Company Detail
Table 47. Hikma Pharmaceuticals Business Overview
Table 48. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product
Table 49. Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 50. Hikma Pharmaceuticals Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Neuromuscular Blocking Drug Product
Table 54. Merck Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Neuromuscular Blocking Drug Product
Table 59. Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer Neuromuscular Blocking Drug Product
Table 64. Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Neuromuscular Blocking Drug Product
Table 69. Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AbbVie Company Detail
Table 72. AbbVie Business Overview
Table 73. AbbVie Neuromuscular Blocking Drug Product
Table 74. AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 75. AbbVie Recent Development
Table 76. GSK Company Detail
Table 77. GSK Business Overview
Table 78. GSK Neuromuscular Blocking Drug Product
Table 79. GSK Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 80. GSK Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 1. Global Neuromuscular Blocking Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Non-polarizing Agents
Table 3. Key Players of Depolarizing Agents
Table 4. Global Neuromuscular Blocking Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Neuromuscular Blocking Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neuromuscular Blocking Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neuromuscular Blocking Drug Market Share by Region (2018-2023)
Table 8. Global Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neuromuscular Blocking Drug Market Share by Region (2024-2029)
Table 10. Neuromuscular Blocking Drug Market Trends
Table 11. Neuromuscular Blocking Drug Market Drivers
Table 12. Neuromuscular Blocking Drug Market Challenges
Table 13. Neuromuscular Blocking Drug Market Restraints
Table 14. Global Neuromuscular Blocking Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neuromuscular Blocking Drug Market Share by Players (2018-2023)
Table 16. Global Top Neuromuscular Blocking Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Table 17. Ranking of Global Top Neuromuscular Blocking Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neuromuscular Blocking Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuromuscular Blocking Drug Product Solution and Service
Table 21. Date of Enter into Neuromuscular Blocking Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuromuscular Blocking Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Neuromuscular Blocking Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neuromuscular Blocking Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neuromuscular Blocking Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Neuromuscular Blocking Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neuromuscular Blocking Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Neuromuscular Blocking Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Hikma Pharmaceuticals Company Detail
Table 47. Hikma Pharmaceuticals Business Overview
Table 48. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product
Table 49. Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 50. Hikma Pharmaceuticals Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Neuromuscular Blocking Drug Product
Table 54. Merck Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Neuromuscular Blocking Drug Product
Table 59. Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer Neuromuscular Blocking Drug Product
Table 64. Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Neuromuscular Blocking Drug Product
Table 69. Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AbbVie Company Detail
Table 72. AbbVie Business Overview
Table 73. AbbVie Neuromuscular Blocking Drug Product
Table 74. AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 75. AbbVie Recent Development
Table 76. GSK Company Detail
Table 77. GSK Business Overview
Table 78. GSK Neuromuscular Blocking Drug Product
Table 79. GSK Revenue in Neuromuscular Blocking Drug Business (2018-2023) & (US$ Million)
Table 80. GSK Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Neuromuscular Blocking Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Neuromuscular Blocking Drug Market Share by Type: 2022 VS 2029
Figure 3. Non-polarizing Agents Features
Figure 4. Depolarizing Agents Features
Figure 5. Global Neuromuscular Blocking Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Neuromuscular Blocking Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Neuromuscular Blocking Drug Report Years Considered
Figure 12. Global Neuromuscular Blocking Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Neuromuscular Blocking Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Neuromuscular Blocking Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Neuromuscular Blocking Drug Market Share by Players in 2022
Figure 16. Global Top Neuromuscular Blocking Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Neuromuscular Blocking Drug Revenue in 2022
Figure 18. North America Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 20. United States Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 24. Germany Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Neuromuscular Blocking Drug Market Share by Region (2018-2029)
Figure 32. China Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 40. Mexico Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 44. Turkey Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 51. AbbVie Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 52. GSK Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Neuromuscular Blocking Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Neuromuscular Blocking Drug Market Share by Type: 2022 VS 2029
Figure 3. Non-polarizing Agents Features
Figure 4. Depolarizing Agents Features
Figure 5. Global Neuromuscular Blocking Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Neuromuscular Blocking Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Neuromuscular Blocking Drug Report Years Considered
Figure 12. Global Neuromuscular Blocking Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Neuromuscular Blocking Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Neuromuscular Blocking Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Neuromuscular Blocking Drug Market Share by Players in 2022
Figure 16. Global Top Neuromuscular Blocking Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Neuromuscular Blocking Drug Revenue in 2022
Figure 18. North America Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 20. United States Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 24. Germany Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Neuromuscular Blocking Drug Market Share by Region (2018-2029)
Figure 32. China Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 40. Mexico Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 44. Turkey Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 51. AbbVie Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 52. GSK Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
